PRA Health Sciences (PRA) is dedicated to ensuring quality Aggregate Safety Reports are delivered to our sponsor and MAH partners. Our experienced team of talented Pharmacovigilance professionals offer clear, comprehensive, and effective processes for successful development of Aggregate Safety Reports. Through our use of innovative technologies, the provision of safety data is automated and team review of the Aggregate Safety Reports can be electronically tracked, thereby providing a more streamlined approach to report generation and management.
Ask the Experts: What Role Does Patient Safety Play in Our Industry?
When it comes to safety, PRA puts its patients and its people first. Clinical trials are meticulous, with many moving pieces and crucial steps. It’s…
Pharmacovigilance & Patient Safety
Clinical trial participants help us speed breakthroughs in modern drug development. Our job is to protect them.
Risk Management Services
PRA Health Sciences (PRA) experts have significant experience providing end-to-end risk management services. Our integrated global teams identify…